This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care Will Be A Speaker Sponsor At The American Diabetes Association's EXPO Pittsburgh

Diabetes is the single leading cause of kidney failure in the U.S., accounting for about 44 percent of the people who start treatment for kidney failure each year. To help raise awareness of the links between diabetes and chronic kidney disease (CKD), Fresenius Medical Care North America (FMCNA), the nation’s leading network of dialysis facilities, will be a speaker sponsor at the American Diabetes Association (the Association) EXPO Pittsburgh, to be held at the David L. Lawrence Convention Center, on Saturday, Nov. 5, from 9:00 a.m. – 4:00 p.m.

More than 4,000 attendees are expected to attend the free EXPO event, which includes health screenings, cooking demonstrations, product and service exhibitors, along with leading experts talking about diabetes management and prevention. FMCNA will host an exhibit at Booth 519, and will also sponsor multiple presentations of " Chronic Kidney Disease: Are You at Risk?” in the booth classroom space.

This seminar will include an overview of FMCNA's Treatment Options Program (TOPs) education sessions, which are held across the U.S. for people at risk for CKD. Anyone with a family history of kidney disease or other risk factors, such as diabetes or high blood pressure, is encouraged to attend. The sessions provide information about CKD management and the treatments available when it leads to kidney failure. Attendees will have the opportunity to register for a TOPs class offered near them.

"There is a strong correlation between diabetes and kidney disease, so people need to understand the symptoms and risk factors associated with CKD," said Laura Conaway, regional vice president, Fresenius Medical Care. "If you have diabetes or high blood pressure, it's especially important to get regular screenings and be more aware of your overall health."

CKD disproportionately affects African-Americans, Hispanics, Asians, American Indians and senior citizens, and being overweight also increases the chances of developing CKD. There is an association because these groups are at higher risk for diabetes and high blood pressure.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs